The Cheese - Bougie Use in the Difficult Airway

When intubating patients with anatomically or physiologically challenging airways, first-pass success is of utmost importance to minimize procedural complications (1). According to the INTUBE trial, two or more attempts at intubation were associated with an increased risk for major adverse events (2). Specifically, the risk of severe hypoxemia increased from 5% on the first pass to 20% on the second pass and 30% on the third pass. Let’s examine whether the bougie may be a useful adjunct to improve first-pass success in the Emergency Department (ED) and potentially minimize the risk of severe hypoxemia and other adverse events.

The Data

There are two recent prominent studies examining the use of the bougie in the ED and whether it improves first-pass success:

  • The BOUGIE trial, released in 2021, was a multi-center randomized control trial (RCT) across 7 EDs and 8 intensive care units (ICUs) across 11 hospitals in the United States, examining 1106 patients undergoing endotracheal (ET) intubation. The patients were randomized into 2 groups: ET intubation with a bougie (n=556) or ET intubation with a malleable stylet and standard geometry blades (n = 546). Both video (75% of intubation attempts) and direct (25% of intubation attempts) laryngoscopy were used. The primary outcome was first-pass success. The secondary outcome was hypoxemia below SpO2 80%. The results showed no significant difference in outcomes with the use of a bougie.

  • The BEAM trial, released in 2018, was completed at Hennepin County Medical Center in Minneapolis, MN. This was a RCT performed in the ED with 757 patients randomized to 2 groups: ET intubation with a bougie (n=381) or ET intubation with a stylet (n = 376). The primary outcome was first-pass success in patients with at least 1 difficult airway characteristic (i.e. body fluids obscuring the laryngeal view, airway obstruction or edema, obesity, short neck, small mandible, large tongue, facial trauma, or C-spine immobilization). The study found that first-pass success was higher with the bougie (96%) than with the stylet (82%) in patients with difficult airway characteristics.

Discussion

  • Both studies are both high-powered RCTs with strong data. The BEAM trial focuses more on difficult airways, which emphasizes the importance of the bougie as an adjunct when anticipating challenging intubations. Always having a bougie available, and even reaching for it first when anticipating a poor view or dirty airway may increase your chances of first pass success in the ED.

  • However, as always, there are limitations to these studies. Regarding the BEAM trial, Hennepin County is known to have a preferred practice of teaching their residents from day one to intubate first with bougie assistance, and nursing and RT are trained to assist the residents in threading the ET tube when the bougie is passed. This practice may introduce some bias into their success rates due to it being their preferred method as an institution. When generalized to other institutions in the BOUGIE trial, the positive effect of the bougie was lost, possibly due to this familiarity bias.

  • The BOUGIE trial, however, also has its limitations. Their exclusion criteria likely did not allow many difficult airways to be included. Patients requiring emergent intubation were excluded, and any patient who was deemed optimal for hyper-angulated blade use was excluded from the data. Additionally, approximately 45% of patients were intubated for altered mental status, which may suggest that those airways were less emergent and had lower risk of complications or significant pre-existing hypoxemia or cardiovascular distress.

 

Takeaways

The bougie can be a very useful tool when attempting to intubate, especially when facing a difficult airway. However, familiarity with the tool likely increases one’s ability to successfully intubate with it on the first-pass attempt. At minimum, these trials suggest that practicing with the bougie in simulation and less challenging intubation attempts may help ED physicians become more adept at using it when facing more difficult airways.

 

Authored by Kathryn McGregor, MD; Taylor Wahrenbrock, MD; and Eric Leser, MD.

 

Sources

  1. Jabaley CS. Managing the Physiologically Difficult Airway in Critically Ill Adults. Crit Care. 2023 Mar 21;27(1):91. doi: 10.1186/s13054-023-04371-3. PMID: 36941620; PMCID: PMC10029275.

  2. Russotto V, Myatra SN, Laffey JG, Tassistro E, Antolini L, Bauer P, Lascarrou JB, Szuldrzynski K, Camporota L, Pelosi P, Sorbello M, Higgs A, Greif R, Putensen C, Agvald-Öhman C, Chalkias A, Bokums K, Brewster D, Rossi E, Fumagalli R, Pesenti A, Foti G, Bellani G; INTUBE Study Investigators. Intubation Practices and Adverse Peri-intubation Events in Critically Ill Patients From 29 Countries. JAMA. 2021 Mar 23;325(12):1164-1172. doi: 10.1001/jama.2021.1727. Erratum in: JAMA. 2021 Jun 22;325(24):2507. doi: 10.1001/jama.2021.9012. PMID: 33755076; PMCID: PMC7988368.

  3. Driver BE, Semler MW, Self WH, Ginde AA, Trent SA, Gandotra S, Smith LM, Page DB, Vonderhaar DJ, West JR, Joffe AM, Mitchell SH, Doerschug KC, Hughes CG, High K, Landsperger JS, Jackson KE, Howell MP, Robison SW, Gaillard JP, Whitson MR, Barnes CM, Latimer AJ, Koppurapu VS, Alvis BD, Russell DW, Gibbs KW, Wang L, Lindsell CJ, Janz DR, Rice TW, Prekker ME, Casey JD; BOUGIE Investigators and the Pragmatic Critical Care Research Group. Effect of Use of a Bougie vs Endotracheal Tube With Stylet on Successful Intubation on the First Attempt Among Critically Ill Patients Undergoing Tracheal Intubation: A Randomized Clinical Trial. JAMA. 2021 Dec 28;326(24):2488-2497. doi: 10.1001/jama.2021.22002. PMID: 34879143; PMCID: PMC8655668.

  4. Driver BE, Prekker ME, Klein LR, Reardon RF, Miner JR, Fagerstrom ET, Cleghorn MR, McGill JW, Cole JB. Effect of Use of a Bougie vs Endotracheal Tube and Stylet on First-Attempt Intubation Success Among Patients With Difficult Airways Undergoing Emergency Intubation: A Randomized Clinical Trial. JAMA. 2018 Jun 5;319(21):2179-2189. doi: 10.1001/jama.2018.6496. PMID: 29800096; PMCID: PMC6134434.